Entero Healthcare Solutions Limited
Book Built Issue IPO · NSE, BSE
- Price band
- ₹1195 - ₹1258
- Lot size
- 11 shares
- Issue amount
- ₹1,600 cr
- Total subscription
- 1.56×
- Opens
- 9 Feb 2024
- Closes
- 13 Feb 2024
- Allotment
- 14 Feb 2024
- Listing
- 16 Feb 2024
Offer at a glance
Issue overview
- Issue size
- 1,27,18,600 shares
- Face value
- ₹10 Per Equity Share
- Minimum investment
- ₹13,145
- Fresh issue
- ₹1,000 cr
- Offer for sale
- ₹600 cr
- Registrar
- Link Intime India Private Limited
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹13,838
- Issue type
- Book Built Issue IPO
- Shares before issue
- 1,60,66,886
- Shares after issue
- 2,40,16,011
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 11 | ₹13,838 |
| sHNI | 15 | 165 | ₹2,07,570 |
| bHNI | 73 | 803 | ₹10,10,174 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 477.6 | 1,092.72 |
| RETAIL | 159.2 | 219.38 |
| NIB | 238.8 | 53.69 |
| HNIs 2+ | 79.6 | 26.78 |
| HNIs 10+ | 159.2 | 26.91 |
| EMPLOYEES | 8.84 | 11.71 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| EPS | 9.7 | 0 | 0 |
| ROE | -2.66 | -7.35 | -4.23 |
| ROCE | 6.05 | 1.49 | 1.88 |
| RONW | -1.86 | -5.23 | -3.15 |
| PRE IPO(PE) | -3.15 | 0 | 0 |
| POST IPO(PE) | 0 | 0 | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Entero Healthcare Solutions Limited was founded in 2018 and is a leading distributor of healthcare products in India. Using a technology-driven platform, the company supplies healthcare products to pharmacies, hospitals, and clinics across the country. Key Highlights: Growing Customer Base: Served 39,500+ retail customers in 2021, 64,200+ in 2022, and 81,400+ in 2023. Also served 1,600+ hospitals in 2021, 2,500+ in 2022, and 3,400+ in 2023. Strong Manufacturer Network: Partnered with 1,900+ healthcare product manufacturers, offering access to 64,500+ product SKUs (as of March 31, 2023). Extensive Infrastructure: Operates 73 warehouses in 37 cities across 19 states and union territories, covering 495 districts in India. Large Workforce: As of March 31, 2023, the company has 3,014 employees across various departments. With its vast distribution network and strong industry relationships, Entero Healthcare Solutions continues to expand its reach in the healthcare sector.
Strengths
- Proprietary technology platform: Enhances operational efficiency and delivers better customer service.
- Strong expansion record: Demonstrates steady growth in reach, revenue, and overall business scale.
- Unique integrated model: Offers end-to-end commercial and supply chain solutions that set the company apart.
- Experienced leadership team: Guided by seasoned promoters and skilled senior management for effective decision-making.
Risk factors
- Past financial losses: Indicate potential instability and raise concerns about long-term sustainability.
- High working capital requirements: Can strain financial resources and create cash flow pressure.
- Competitive and consolidating industry: Market pressures may impact operations and reduce margins.
- Negative cash flows: Pose challenges to maintaining financial stability and smooth operations.
Promoters
Prabhat Agrawal
Prem Sethi
OrbiMed Asia III Mauritius Limited
Registrar & documents
Lead manager
ICICI Securities Limited, Dam Capital Advisors Limited, Jefferies India Private Limited, Jm Financial Limited, SBI Capital Markets Limited
Registrar & contacts
Link Intime India Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
Plot No. I-35, Building - B Industrial Area Phase - I 13/7 Mathura Road, Faridabad 121 003
+91 22-69019100
[email protected]Company website ↗Understanding ENTERO IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.